ACROFAN

GeneMatrix Participates in MEDLAB 2020, the World's Largest Medical Equipment & Devices Expo

Published : Tuesday, February 4, 2020, 6:52 pm
ACROFAN=Seunghee Shin | seunghee.shin@acrofan.com | SNS
GeneMatrix (CEO Kim Soo-ok) announced on the 4th that it participates in 'Medlab Middle East 2020', the world's largest exhibition of diagnostic medical equipment and devices based in the Middle East.

Medlab 2020, held from February 3 to 6, is co-hosted with Arab Health, the largest medical device exhibition in the Middle East, and is expected to attract about 20,000 people from 600 companies in 35 countries.

GeneMatrix booth at Medlab 2020 (Photo by: GeneMatrix)

GeneMatrix participates in the exhibition and will focus on promoting sex and respiratory infection testing products of the main pipeline, NeoPlex™, which applied the company's original technology, C-TagTM technology. Both of the company's main products received European CE certification last year.

Currently, GeneMatrix has multiple product portfolios in its respiratory testing line. In the respiratory virus panel line, "NeoPlex RV-Panel A" and "NeoPlex RV-Panel B" have been developed, while the bacterial panel line has developed "NeoPlex RB-8".

In particular, "NeoPlex RV-Panel A" can collectively diagnose 10 major respiratory viral pathogens, including influenza A/B, respiratory syncytial virus A/B, parainfluenza 1/2/3, and adenovirus, in a single test. Moreover, "NeoPlex RV-Panel B" is capable of simultaneous diagnosis of 9 respiratory viruses, including coronavirus, enterovirus, and rhinovirus.

GeneMatrix's "NeoPlex RV-Panel B" has completed clinical trials and is ready for early market release. In addition, GeneMatrix said it plans to continue to market products at not only Medlab but also other overseas exhibitions and focus on exporting.

Copyright © acrofan All Right Reserved


    Acrofan     |     Contact Us : guide@acrofan.com     |     Contents API : RSS

Copyright © Acrofan All Right Reserved